Icahn School of Medicine at Mount Sinai: Depressive Disorder, Major trials
The registry lists 17 Depressive Disorder, Major studies with Icahn School of Medicine at Mount Sinai as lead sponsor. 4 are open to participants now and 5 have results posted.
Phase 1 1Phase 2 7Phase 4 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Neutralizing Interleukin (IL)-6RecruitingNCT07493317Phase 2
- Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive DisorderRecruitingNCT06592833Phase 2
- Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of DepressionRecruitingNCT06559826Phase 2
- Neural Circuit Effects of Ketamine in DepressionRecruitingNCT06213324Phase 4
- Targeting IL-17A for Treatment-Resistant DepressionCompletedNCT04979910Phase 2Results posted
- Study to Treat Major Depressive Disorder (MDD) With a New MedicationCompletedNCT02149836Phase 2Results posted
- Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the TreatCompletedNCT01971203Not applicableResults posted
- The Role Of Omega-3 Fatty Acids In Adolescent DepressionCompletedNCT00962598Phase 2Results posted
- Cysteamine Therapy for Major Depressive DisorderTerminatedNCT00715559Not applicableResults posted
- Network Neurofeedback Using 7-Tesla MRI to Reduce Rumination Levels in DepressionSuspendedNCT05933148Not applicable
- Invasive Decoding and Stimulation of Altered Reward Computations in Depression PatientsCompletedNCT05239780Not applicable
- Real-time Biofeedback With 7-Tesla MRI for Treatment of DepressionCompletedNCT04138680Not applicable
- MRI Studies of Emotion in DepressionCompletedNCT02429011
- Cognitive Training for Mood and Anxiety DisordersCompletedNCT02256566Not applicable
- Cognitive Training for DepressionCompletedNCT01936506Phase 1/2
- Cognitive Training for Depression IICompletedNCT01934491Not applicable
- Prevention of Depression in HIV/HCV Co-infected Substance Abuse PatientsTerminatedNCT00655226Not applicable